Infezioni in Medicina,
Journal Year:
2022,
Volume and Issue:
30(4)
Published: Dec. 1, 2022
The
SARS-CoV-2
Omicron
variant
(B.1.1.529)
has
been
the
most
recent
of
concern
(VOC)
established
by
World
Health
Organization
(WHO).
Because
its
greater
infectivity
and
immune
evasion,
this
quickly
became
dominant
type
circulating
worldwide.
Our
literature
review
thoroughly
explains
current
state
emergence,
particularly
comparing
different
omicron
subvariants,
including
BA.2,
BA.1,
BA.3.
Such
elaboration
would
be
based
on
structural
variations,
mutations,
clinical
manifestation,
transmissibility,
pathogenicity,
vaccination
effectiveness.
notable
difference
between
three
subvariants
is
insufficiency
deletion
(Δ69-70)
in
spike
protein,
which
results
a
lower
detection
rate
(S)
gene
target
known
as
failure
(SGTF).
Furthermore,
BA.2
had
stronger
affinity
to
human
Angiotensin-converting
Enzyme
(hACE2)
receptor
than
other
sub-lineages.
Regarding
number
BA.1.1
(40),
followed
BA.3,
BA.3
with
39,
34,
31
respectively.
In
addition,
have
transmissibility
sub-lineages
(BA.1
BA.1.1).
These
characteristics
are
primarily
responsible
for
Omicron's
vast
geographical
spread
high
contagiousness
rates,
New England Journal of Medicine,
Journal Year:
2022,
Volume and Issue:
387(1), P. 21 - 34
Published: June 15, 2022
The
protection
conferred
by
natural
immunity,
vaccination,
and
both
against
symptomatic
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
with
the
BA.1
or
BA.2
sublineages
of
omicron
(B.1.1.529)
variant
is
unclear.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: June 2, 2022
Abstract
SARS-CoV-2
Omicron
BA.1
and
BA.2
subvariants
are
genetically
divergent.
We
conducted
a
matched,
test-negative,
case-control
study
to
estimate
duration
of
protection
the
second
third/booster
doses
mRNA
COVID-19
vaccines
against
infections
in
Qatar.
BNT162b2
effectiveness
was
highest
at
46.6%
(95%
CI:
33.4–57.2%)
symptomatic
51.7%
43.2–58.9%)
first
three
months
after
dose,
but
declined
~10%
or
below
thereafter.
Effectiveness
rebounded
59.9%
51.2–67.0%)
43.7%
36.5–50.0%),
respectively,
month
booster
before
declining
again.
hospitalization
death
70–80%
dose
>90%
dose.
mRNA-1273
vaccine
showed
similar
patterns.
provide
comparable,
moderate,
short-lived
infections,
strong
durable
death.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(1), P. 167 - 167
Published: Jan. 5, 2023
The
COVID-19
pandemic
has
created
significant
concern
for
everyone.
Recent
data
from
many
worldwide
reports
suggest
that
most
infections
are
caused
by
the
Omicron
variant
and
its
sub-lineages,
dominating
all
previously
emerged
variants.
numerous
mutations
in
Omicron’s
viral
genome
sub-lineages
attribute
it
a
larger
amount
of
fitness,
owing
to
alteration
transmission
pathophysiology
virus.
With
rapid
change
structure,
sub-variants,
namely
BA.1,
BA.2,
BA.3,
BA.4,
BA.5,
dominate
community
with
an
ability
escape
neutralization
efficiency
induced
prior
vaccination
or
infections.
Similarly,
several
recombinant
sub-variants
Omicron,
XBB,
XBD,
XBF,
etc.,
have
emerged,
which
better
understanding.
This
review
mainly
entails
changes
due
having
higher
number
mutations.
binding
affinity,
cellular
entry,
disease
severity,
infection
rates,
importantly,
immune
evading
potential
them
discussed
this
review.
A
comparative
analysis
Delta
other
variants
evolved
before
gives
readers
in-depth
understanding
landscape
infection.
Furthermore,
discusses
range
abilities
possessed
approved
antiviral
therapeutic
molecules
neutralizing
antibodies
functional
against
sub-variants.
evolution
is
causing
infections,
but
broader
aspect
their
not
been
explored.
Thus,
scientific
should
adopt
elucidative
approach
obtain
clear
idea
about
recently
including
variants,
so
effective
vaccines
drugs
can
be
achieved.
This,
turn,
will
lead
drop
cases
and,
finally,
end
pandemic.
Journal of Medical Virology,
Journal Year:
2022,
Volume and Issue:
94(10), P. 4780 - 4791
Published: June 10, 2022
The
Omicron
variant
of
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
now
spread
throughout
world.
We
used
computational
tools
to
assess
spike
infectivity,
transmission,
and
pathogenicity
(BA.1)
sub-variants
(BA.1.1,
BA.2,
BA.3)
in
this
study.
BA.1
39
mutations,
BA.1.1
40
BA.2
31
BA.3
34
with
21
shared
mutations
between
all.
observed
11
common
Omicron's
receptor-binding
domain
(RBD)
sub-variants.
In
analysis,
Y505H,
N786K,
T95I,
N211I,
N856K,
V213R
omicron
are
predicted
be
deleterious.
Due
major
effect
characterizing
RBD,
we
found
that
had
a
higher
positive
electrostatic
surface
potential.
This
could
increase
interaction
RBD
negative
potential
human
angiotensin-converting
enzyme
(hACE2).
affinity
for
hACE2
increased
transmission
when
compared
wild-type
(WT).
Negative
N-terminal
(NTD)
protein
value
indicates
binds
receptors
less
efficiently
than
WT.
Given
at
least
one
receptor
is
highly
expressed
lung
bronchial
cells,
NTD
factors
contributing
why
thought
harmful
lower
tract.
Among
sub-lineages,
have
BA.1.1.
mutated
residues
(K478),
(R400,
R490,
R495),
(R397
H499)
formation
new
salt
bridges
hydrogen
bonds.
sub-variant
Receptor-binding
Motif
(RBM)
such
as
Q493R,
N501Y,
Q498,
T478K,
Y505H
all
contribute
significantly
binding
ACE2.
Interactions
493,
496,
498,
501
seem
restore
ACE2
effectiveness
lost
due
other
like
K417N.
Journal of Medical Virology,
Journal Year:
2022,
Volume and Issue:
95(1)
Published: Sept. 13, 2022
As
of
November
2021,
several
SARS-CoV-2
variants
appeared
and
became
dominant
epidemic
strains
in
many
countries,
including
five
concern
(VOCs)
Alpha,
Beta,
Gamma,
Delta,
Omicron
defined
by
the
World
Health
Organization
during
COVID-19
pandemic.
August
2022,
is
classified
into
main
lineages,
BA.1,
BA.2,
BA.3,
BA.4,
BA.5
some
sublineages
(BA.1.1,
BA.2.12.1,
BA.2.11,
BA.2.75,
BA.4.6)
(https://www.gisaid.org/).
Compared
to
previous
VOCs
(Alpha,
Delta),
all
lineages
have
most
highly
mutations
spike
protein,
with
50
accumulated
throughout
genome.
Early
data
indicated
that
BA.2
sublineage
had
higher
infectivity
more
immune
escape
than
early
wild-type
(WT)
strain,
VOCs,
BA.1.
Recently,
global
surveillance
suggest
a
transmissibility
BA.4/BA.5
BA.1.1
becoming
strain
countries
globally.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
154, P. 113522 - 113522
Published: Aug. 15, 2022
Since
the
start
of
COVID-19
pandemic,
numerous
variants
SARS-CoV-2
have
been
reported
worldwide.
The
advent
concern
(VOCs)
raises
severe
concerns
amid
serious
containment
efforts
against
that
include
physical
measures,
pharmacological
repurposing,
immunization,
and
genomic/community
surveillance.
Omicron
variant
(B.1.1.529)
has
identified
as
a
highly
modified,
contagious,
crucial
among
five
VOCs
SARS-CoV-2.
increased
affinity
spike
protein
(S-protein),
host
receptor,
angiotensin
converting
enzyme-2
(ACE-2),
due
to
higher
number
mutations
in
receptor-binding
domain
(RBD)
S-protein
proposed
primary
reason
for
decreased
efficacy
majorly
available
vaccines
transmissible
nature
variant.
Because
its
significant
competitive
advantage,
sublineages
swiftly
surpassed
other
become
dominant
circulating
lineages
nations.
prevalent
strain
United
Kingdom
South
Africa.
Furthermore,
emergence
recombinant
through
conjunction
with
or
by
mixing
variant's
sublineages/subvariants
poses
major
threat
humanity.
This
various
issues
hazards
regarding
sublineages,
such
an
breakout
susceptible
populations
fully
vaccinated
persons.
As
result,
understanding
features
genetic
implications
this
is
crucial.
Hence,
we
explained
depth
evolution
analyzed
repercussions
on
infectiousness,
dissemination
ability,
viral
entry
mechanism,
immune
evasion.
We
also
presented
viewpoint
feasible
strategies
precluding
counteracting
any
future
catastrophic
spread
omicron
could
result
detrimental
wave
cases.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(4), P. 944 - 944
Published: April 10, 2023
The
COVID-19
pandemic
caused
by
SARS-CoV-2
is
associated
with
a
lower
fatality
rate
than
its
SARS
and
MERS
counterparts.
However,
the
rapid
evolution
of
has
given
rise
to
multiple
variants
varying
pathogenicity
transmissibility,
such
as
Delta
Omicron
variants.
Individuals
advanced
age
or
underlying
comorbidities,
including
hypertension,
diabetes
cardiovascular
diseases,
are
at
higher
risk
increased
disease
severity.
Hence,
this
resulted
in
an
urgent
need
for
development
better
therapeutic
preventive
approaches.
This
review
describes
origin
human
coronaviruses,
particularly
well
sub-variants.
Risk
factors
that
contribute
severity
implications
co-infections
also
considered.
In
addition,
various
antiviral
strategies
against
COVID-19,
novel
repurposed
drugs
targeting
viral
host
proteins,
immunotherapeutic
strategies,
discussed.
We
critically
evaluate
current
emerging
vaccines
their
efficacy,
immune
evasion
new
impact
on
diagnostic
testing
examined.
Collectively,
global
research
public
health
authorities,
along
all
sectors
society,
prepare
upcoming
future
coronavirus
outbreaks.
Biology,
Journal Year:
2023,
Volume and Issue:
12(9), P. 1267 - 1267
Published: Sept. 21, 2023
SARS-CoV-2,
the
virus
that
causes
COVID-19,
is
prone
to
mutations
and
generation
of
genetic
variants.
Since
its
first
outbreak
in
2019,
SARS-CoV-2
has
continually
evolved,
resulting
emergence
several
lineages
variants
concern
(VOC)
have
gained
more
efficient
transmission,
severity,
immune
evasion
properties.
The
World
Health
Organization
given
these
names
according
letters
Greek
Alphabet,
starting
with
Alpha
(B.1.1.7)
variant,
which
emerged
2020,
followed
by
Beta
(B.1.351),
Gamma
(P.1),
Delta
(B.1.617.2),
Omicron
(B.1.1.529)
This
review
explores
variation
among
different
VOCs
how
made
a
global
impact
on
pandemic.
International Journal of Quantum Chemistry,
Journal Year:
2023,
Volume and Issue:
123(16)
Published: April 28, 2023
Abstract
The
major
challenges
encountered
by
medical
researchers
in
developing
new
drugs
are
time
consumption,
increased
cost,
establishing
a
safety
profile
for
the
drugs,
poor
solubility,
and
inadequate
experimental
data.
In
its
theoretical
aspects,
chemical
graph
theory
plays
vital
role
drug
design
development
analyzing
structural
parameters
of
molecules.
Topological
indices
aim
at
mathematical
representation
molecular
structure,
which
is
used
to
analyze
effectiveness
enhance
process.
this
study,
we
consider
certain
recently
such
as
dexamethasone,
molnupiravir,
nirmatrelvir,
ivermectin,
ribavirin,
baricitinib,
favipiravir,
duvelisib,
L‐ascorbic
acid,
sofosbuvir,
remdesivir,
pioglitazone
omicron,
delta
other
variants
coronaviruses.
For
these
molecules,
propose
generalized
form
reverse
degree
compute
their
associated
topological
with
limiting
behaviors.
We
undertake
QSPR
study
on
potential
reverse‐degree
using
linear
cubic
regression
models.